Tower Research Capital LLC (TRC) - TALARIS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,703
+16793.8%
962
-88.9%
0.00%
-100.0%
Q1 2023$16
+77.8%
8,666
-4.1%
0.00%
Q4 2022$9
-100.0%
9,034
+4.6%
0.00%
Q3 2022$23,000
+53.3%
8,637
+156.4%
0.00%
Q2 2022$15,000
-81.0%
3,369
-58.0%
0.00%
-100.0%
Q1 2022$79,000
+618.2%
8,013
+1031.8%
0.00%
Q4 2021$11,000
+10.0%
708
-9.8%
0.00%
Q3 2021$10,000
+900.0%
785
+1166.1%
0.00%
Q2 2021$1,000620.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$28,857,00027.11%
Aisling Capital Management LP 682,923$6,720,0003.63%
Cormorant Asset Management, LP 1,174,723$11,559,0000.89%
Artal Group S.A. 2,064,262$20,312,0000.85%
SECTORAL ASSET MANAGEMENT INC 228,624$2,250,0000.40%
Logos Global Management LP 306,236$3,013,0000.39%
Eventide Asset Management 1,561,092$15,361,0000.24%
Blackstone Inc. 8,089,315$79,599,0000.20%
HHLR ADVISORS, LTD. 698,797$6,876,0000.14%
VIKING GLOBAL INVESTORS LP 3,289,617$32,370,0000.13%
View complete list of TALARIS THERAPEUTICS INC shareholders